During this time, Professor Borovick acquired vast experience in many scientific OSI-744 solubility dmso fields and management activities. He took the lead in several scientific projects to increase protection methods against highly infectious diseases. In 1993, and until the end of the Cold War, Professor Borovick served as head chief of the newly established RCT&HRB. This was a painful transition period for many in science, who, prior to this, were

often involved in secure and opaque government-funded research and development projects. In contrast to many of his peers, Professor Borovick saw this tumultuous period as an opportunity to bring about real change in scientific research in his country. He applied all his former management experience to bringing new scientific talent to the RCT&HRB and to ensure that it engaged in credible well-funded scientific research. This was done at a time when many scientific institutes were falling into decay and receiving little to no funding. During this time, Professor Borovick traveled extensively

to build a favorable international image of the new institute, and to develop the institute’s natural and capital resources. He participated in international events in the U.S., Sweden, Germany, France, Switzerland, Slovakia, Bulgaria, Japan, and many other countries. His presentations covered a broad range of topics, selleck inhibitor but always presented the positive achievements of Russian science in the fields of toxicology and hygiene. Under Professor Borovick’s leadership, the RCT&HRB participated in a wide range of international science collaborations. Through these efforts, he built international relationships with scientists who worked in areas

as diverse as medicine, ecology, aerobiology, vaccine development, vaccine delivery systems, and biological plant protection agents. Professor Borovick also promoted greater collaboration and participation of RCT&HRB scientists in global scientific societies and networks, which allowed them to stay informed about the latest achievements in science. The RCT&HRB quickly assumed a life of its own and became involved in a myriad of state and private contracts, including pre-clinical crotamiton trials of drugs and immune-biological preparations. These achievements gave Professor Borovick greater freedom to create and participate actively in studies and projects for biosafety, bioterrorism countermeasures, the development of innovative technologies for the recovery of contaminated territories, development of molecular-genetic approaches to the formulation of novel medical preparations with unique therapeutic and prophylactic properties, ecological and toxicological assessment of genetically-engineered plants, and others. Professor Borovick established cordial business relations with the individuals at the International Science and Technology Center, CRDF, U.S. Department of State, and other international organizations.